Hyundai Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hyundai Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 8 340 KRW Market Closed

Market Cap: ₩266.9B

	Hyundai Pharmaceutical Co Ltd KRX:004310	KR
H	Hormel Foods Corp SWB:HO7	US
	Jabil Inc NYSE:JBL	US

Profitability Summary

Hyundai Pharmaceutical Co Ltd's profitability score is 40/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

42%

Declining Gross Margin

43% > 40%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

0% > 2%

Negative Free Cash Flow Margin

-1%

Negative 3Y Average Free Cash Flow Margin

-6%

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-9%

ROIC is Increasing

0% > 3%

View All

Hide

Collapse

40 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.